Literature DB >> 4026801

Characterization of human tissue carnosinase.

J F Lenney, S C Peppers, C M Kucera-Orallo, R P George.   

Abstract

Human tissue carnosinase (EC 3.4.13.3) had optimum activity at pH9.5 and was a cysteine peptidase, being activated by dithiothreitol and inhibited by p-hydroxymercuribenzoate. By optimizing assay conditions, the activity per g of tissue was increased 10-fold compared with values in the literature. The enzyme was present in every human tissue assayed and was entirely different from serum carnosinase. Highly purified tissue carnosinase had a broader specificity than hog kidney carnosinase. Although tissue carnosinase was very strongly inhibited by bestatin, it did not hydrolyse tripeptides, and thus appears to be a dipeptidase rather than an aminopeptidase. It had a relative molecular mass of 90 000, an isoelectric point of 5.6, and a Km value of 10 mM-carnosine. Two forms of kidney and brain carnosinase were separated by high-resolution anion-exchange chromatography, although only one form was detected by various electrophoretic methods. Homocarnosinase and Mn2+-independent carnosinase were not detected in human tissues, although these enzymes are present in rat and hog kidney.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026801      PMCID: PMC1145034          DOI: 10.1042/bj2280653

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Specificity and distribution of mammalian carnosinase.

Authors:  J F Lenney
Journal:  Biochim Biophys Acta       Date:  1976-03-11

2.  Homocarnosinase: a hog kidney dipeptidase with a broader specificity than carnosinase.

Authors:  J F Lenney; S C Kan; K Siu; G H Sugiyama
Journal:  Arch Biochem Biophys       Date:  1977-11       Impact factor: 4.013

3.  Peptide transport in rabbit kidney. Studies with L-carnosine.

Authors:  V Ganapathy; F H Leibach
Journal:  Biochim Biophys Acta       Date:  1982-10-07

4.  Inherited differences in mouse kidney carnosinase activity.

Authors:  F L Margolis; M Grillo
Journal:  Biochem Genet       Date:  1984-06       Impact factor: 1.890

5.  Enzymatic and immunological evidence for two forms of carnosinase in the mouse.

Authors:  F L Margolis; M Grillo; C E Brown; T H Williams; R G Pitcher; G J Elgar
Journal:  Biochim Biophys Acta       Date:  1979-10-11

6.  Homocarnosinosis: lack of serum carnosinase is the defect probably responsible for elevated brain and CSF homocarnosine.

Authors:  J F Lenney; S C Peppers; C M Kucera; O Sjaastad
Journal:  Clin Chim Acta       Date:  1983-08-15       Impact factor: 3.786

7.  Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium.

Authors:  J F Lenney; R P George; A M Weiss; C M Kucera; P W Chan; G S Rinzler
Journal:  Clin Chim Acta       Date:  1982-08-18       Impact factor: 3.786

8.  Purification and properties of human pancreas dipeptidase.

Authors:  Y Ito; M Sugiura; S Sawaki
Journal:  J Biochem       Date:  1983-09       Impact factor: 3.387

9.  Purification, characterization and immunocytochemical localization of mouse kidney carnosinase.

Authors:  F L Margolis; M Grillo; N Grannot-Reisfeld; A I Farbman
Journal:  Biochim Biophys Acta       Date:  1983-05-18

10.  Enzyme inhibitors in relation to cancer therapy.

Authors:  T Aoyagi; M Ishizuka; T Takeuchi; H Umezawa
Journal:  Jpn J Antibiot       Date:  1977-12
View more
  18 in total

1.  Carnosine (beta-alanylhistidine) protects from the suppression of contact hypersensitivity by ultraviolet B (280-320 nm) radiation or by cis urocanic acid.

Authors:  V E Reeve; M Bosnic; E Rozinova
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

2.  Extracellular arginine aminopeptidase from Streptococcus gordonii FSS2.

Authors:  J M Goldstein; D Nelson; T Kordula; J A Mayo; J Travis
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Trehalose-Carnosine Prevents the Effects of Spinal Cord Injury Through Regulating Acute Inflammation and Zinc(II) Ion Homeostasis.

Authors:  Alessia Filippone; Irene Paterniti; Irina Naletova; Valentina Greco; Sebastiano Sciuto; Emanuela Esposito; Salvatore Cuzzocrea; Enrico Rizzarelli
Journal:  Cell Mol Neurobiol       Date:  2022-09-19       Impact factor: 4.231

4.  Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications.

Authors:  Zhengzhi Xie; Shahid P Baba; Brooke R Sweeney; Oleg A Barski
Journal:  Chem Biol Interact       Date:  2013-01-09       Impact factor: 5.192

5.  L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities.

Authors:  M A Babizhayev; M C Seguin; J Gueyne; R P Evstigneeva; E A Ageyeva; G A Zheltukhina
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 6.  Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.

Authors:  J P Bai; G L Amidon
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

7.  Gene expression of carnosine-related enzymes and transporters in skeletal muscle.

Authors:  Inge Everaert; Hélène De Naeyer; Youri Taes; Wim Derave
Journal:  Eur J Appl Physiol       Date:  2012-11-04       Impact factor: 3.078

8.  Carnosine supplementation protects rat brain tissue against ethanol-induced oxidative stress.

Authors:  Ummuhani Ozel Turkcu; Ayşe Bilgihan; Gursel Biberoglu; Oznur Mertoglu Caglar
Journal:  Mol Cell Biochem       Date:  2010-01-03       Impact factor: 3.396

Review 9.  Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.

Authors:  Verena Peters; Johannes Zschocke; Claus P Schmitt
Journal:  J Inherit Metab Dis       Date:  2017-10-13       Impact factor: 4.982

10.  Development of multiple reaction monitoring assay for quantification of carnosine in human plasma.

Authors:  Vaibhav Kumar Pandya; Babasaheb Sonwane; Rajeshwari Rathore; A G Unnikrishnan; Sangaralingam Kumaran; Mahesh J Kulkarni
Journal:  RSC Adv       Date:  2020-01-02       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.